HPTN 083-02: factors influencing adherence to injectable PrEP and retention in an injectable PrEP study.
Christina PsarosGeorgia R GoodmanJasper S LeeWhitney S RiceColleen F KelleyTemitope OyedeleLara Esteves CoelhoPraphan PhanuphakYashna SinghKeren MiddelkoopSam GriffithMarybeth McCauleyJames RooneyAlex R RinehartJesse L ClarkVivian GoJeremy SugarmanSheldon D FieldsAdeola AdeyeyeBeatriz GrinsztejnRaphael J LandovitzSteven A Safrennull nullPublished in: Journal of the International AIDS Society (2024)
Respondents viewed injectable PrEP trial participation as a positive experience and a means of enhancing wellbeing. Study site flexibility and affirming clinic environments, inclusive of non-judgemental counselling, were key facilitators of adherence. To support injection persistence, interventions that address structural barriers and promote flexible means of injection delivery may be most effective.